308 related articles for article (PubMed ID: 21460309)
1. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
Kullar R; Davis SL; Levine DP; Rybak MJ
Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
[TBL] [Abstract][Full Text] [Related]
2. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.
Jacob JT; DiazGranados CA
Int J Infect Dis; 2013 Feb; 17(2):e93-e100. PubMed ID: 23089040
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.
Hahn A; Frenck RW; Allen-Staat M; Zou Y; Vinks AA
Ther Drug Monit; 2015 Oct; 37(5):619-25. PubMed ID: 26378371
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-Resistant
Arnold S; Orvin D; Patel M; Schoen K; Wagner J; Jones BM
Hosp Pharm; 2024 Jun; 59(3):329-333. PubMed ID: 38765001
[No Abstract] [Full Text] [Related]
5. AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.
Castañeda X; García-de-la-Mària C; Gasch O; Pericas JM; Armero Y; Soy D; García-González J; Falces C; Ninot S; Almela M; Ambrosioni J; Quintana E; Vidal B; Fuster D; Llopis J; Soto S; Moreno A; Marco F; Miró JM;
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373187
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.
Paul M; Bishara J; Yahav D; Goldberg E; Neuberger A; Ghanem-Zoubi N; Dickstein Y; Nseir W; Dan M; Leibovici L
BMJ; 2015 May; 350():h2219. PubMed ID: 25977146
[TBL] [Abstract][Full Text] [Related]
7. Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's Complicated.
Ortwine JK; Zasowski EJ; Pogue JM; Hanni C; Giuliano C; Casapao AM; Mynatt R; Rybak MJ
Infect Dis Ther; 2019 Dec; 8(4):627-640. PubMed ID: 31637596
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vancomycin area under the curve calculated based on Bayesian approach versus equation-based approach.
Lee E; Yu U; Park JI; Park SI
Int J Clin Pharmacol Ther; 2024 May; 62(5):204-212. PubMed ID: 38329916
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant
Mills AG; Dupper AC; Chacko KI; Alburquerque B; Nadkarni D; Berbel Caban A; Fox L; Gitman MR; Obla A; van Bakel H; Altman DR
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e87. PubMed ID: 37179762
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.
van Hal SJ; Paterson DL; Lodise TP
Antimicrob Agents Chemother; 2013 Feb; 57(2):734-44. PubMed ID: 23165462
[TBL] [Abstract][Full Text] [Related]
11. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA
Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Howden BP; Johnson PD
Antimicrob Agents Chemother; 2013 Apr; 57(4):1654-63. PubMed ID: 23335735
[TBL] [Abstract][Full Text] [Related]
14. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
[TBL] [Abstract][Full Text] [Related]
15. Are vancomycin trough concentrations adequate for optimal dosing?
Neely MN; Youn G; Jones B; Jelliffe RW; Drusano GL; Rodvold KA; Lodise TP
Antimicrob Agents Chemother; 2014; 58(1):309-16. PubMed ID: 24165176
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization.
Brown J; Brown K; Forrest A
Antimicrob Agents Chemother; 2012 Feb; 56(2):634-8. PubMed ID: 22123681
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.
van Hal SJ; Lodise TP; Paterson DL
Clin Infect Dis; 2012 Mar; 54(6):755-71. PubMed ID: 22302374
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
Prybylski JP
Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
[TBL] [Abstract][Full Text] [Related]
19. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.
Neely MN; Kato L; Youn G; Kraler L; Bayard D; van Guilder M; Schumitzky A; Yamada W; Jones B; Minejima E
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203493
[TBL] [Abstract][Full Text] [Related]
20. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
Pai MP; Neely M; Rodvold KA; Lodise TP
Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
